Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  GenMark Diagnostics, Inc    GNMK

GENMARK DIAGNOSTICS, INC (GNMK)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
4.74(c) 4.56(c) 4.24(c) 4.75(c) 4.49(c) Last
182 173 185 981 604 861 450 210 276 611 Volume
-1.66% -3.80% -7.02% +12.03% -5.47% Change
More quotes
Financials ($)
Sales 2017 52,2 M
EBIT 2017 -59,2 M
Net income 2017 -62,2 M
Finance 2017 30,0 M
Yield 2017 -
Sales 2018 69,5 M
EBIT 2018 -50,1 M
Net income 2018 -54,1 M
Debt 2018 18,0 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 4,14x
EV / Sales2018 3,80x
Capitalization 246 M
More Financials
Company
GenMark Diagnostics, Inc. is a molecular diagnostics company.The firm focuses on the development and commercializing of its its proprietary eSensor detection technology.It also manufactures, sells, and supports instruments and molecular tests.The company was founded by Jon Faiz Kayyem on February... 
More about the company
Surperformance© ratings of GenMark Diagnostics, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GENMARK DIAGNOSTICS, INC
01/09GENMARK DIAGNOSTICS, INC. : Results of Operations and Financial Condition (form ..
AQ
01/09GenMark Diagnostics Provides Preliminary Operational and Financial Results fo..
GL
2017GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Con..
GL
2017GENMARK DIAGNOSTICS, INC. : Entry into a Material Definitive Agreement, Creation..
AQ
2017GNMK Law Offices of Howard G. Smith Continues Investigation on Behalf of GenM..
BU
2017GLANCY PRONGAY & MURRAY LLP : Continues Investigation on Behalf of GenMark Diagn..
BU
2017GNMK Law Offices of Howard G. Smith Commences Investigation on Behalf of GenM..
BU
2017GENMARK DIAGNOSTICS : to Present at the Canaccord Genuity Medical Technologies &..
BU
2017GENMARK DIAGNOSTICS, INC : Bronstein, Gewirtz & Grossman, LLC Announces Investig..
AC
2017GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of GenMark Diagn..
BU
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/19Siemens Healthineers on track for March IPO
RE
02/08ATHENAHEALTH : Former GE CEO Jeff Immelt Named Chairman of Athenahealth -- Updat..
DJ
02/07GENERAL ELECTRIC : Former GE CEO Jeff Immelt Named Chairman of Athenahealth
DJ
02/03ROYAL PHILIPS : Investors Seek Answers on Health Fund -- WSJ
DJ
02/02ROYAL PHILIPS : Abraaj Investors Hire Auditor to Trace Money
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Latest Tweets
02/19Analyzing GenMark Diagnostics $GNMK & Alliance HealthCare Services $AIQ  
02/12Research Report Identifies Waste Connections, Hercules Capital, Crown, GenMar.. 
01/31Get the latest ratings for $RLD $WIRE $GNMK $PMC $CTXS in your inbox with Mar.. 
01/28$GNMK - GenMark Diagnostics, Inc #GNMK SVP Sells $20,200.00 in Stock  
01/26Zacks Investment Research Upgrades GenMark Diagnostics $GNMK to “Hold”  
More tweets
Qtime:113
News from SeekingAlpha
01/09GenMark Diagnostics provides preliminary results for 2017 
2017YOUR DAILY PHARMA SCOOP : Geron Update, Acorda Resubmits NDA, Sage Rallies 
2017GenMark's Credibility Is Dented, But The Sell-Off Is Excessive 
2017YOUR DAILY PHARMA SCOOP : A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tu.. 
2017YOUR DAILY PHARMA SCOOP : Anxious Time For Dynavax Longs, VBL Therapeutics Gets .. 
Chart GENMARK DIAGNOSTICS, INC
Duration : Period :
GenMark Diagnostics, Inc Technical Analysis Chart | GNMK | US3723091043 | 4-Traders
Technical analysis trends GENMARK DIAGNOSTICS, INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 11,0 $
Spread / Average Target 145%
EPS Revisions
Managers
NameTitle
Hany Massarany President, Chief Executive Officer & Director
James Charles Fox Chairman
Brian Mitchell Senior Vice President-Operations
Scott Mendel CFO & Principal Accounting Office
Jon Faiz Kayyem Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
GENMARK DIAGNOSTICS, INC1.68%246
THERMO FISHER SCIENTIFIC9.71%84 454
DANAHER3.53%67 849
INTUITIVE SURGICAL12.32%46 714
BOSTON SCIENTIFIC CORPORATION8.15%37 351
ROYAL PHILIPS-1.49%36 131